Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 14, 2024Diabetes

750-P: Association of Glucagon-Like Peptide 1 Receptor Agonists with Incident Parkinson’s Disease in U.S. Older Adults with Type 2 Diabetes

View Full Paper
Ask AI
Bookmark
Share

Authors

HTHUILIN TANGYLYing LüMOMichael S. Okun

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

TANG et al. (2024) studied this question.

synapsesocial.com/papers/68e64c4eb6db6435875dd364https://doi.org/10.2337/db24-750-p
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Parkinson's Disease in Patients with Type 2 Diabetes: A Population‐Based Cohort Study2024 · 10 citations
  2. 22170-P: Association of Newer Glucose-Lowering Drugs with Incident Parkinsonian Disorders in Older Adults with REM Sleep Behavior Disorder and Type 2 Diabetes2026
  3. 3735-P: Association between Glucagon-Like Peptide 1 Receptor Agonists and Risk of Depression in U.S. Older Adults with Type 2 Diabetes—A Population-Based Cohort Study2024
  4. 4Glucagon-like peptide-1 receptor agonists and the risk of Parkinson’s disease in patients with type 2 diabetes: a systematic review and meta-analysis of large-scale real-world data2026
  5. 5772-P: GLP1RA Use and Risk of Pancreatitis and Biliary Disease in Adults with Type 2 Diabetes and Low to Moderate CV Risk2024